Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page
- Check2 days agoChange DetectedPage version updated from v3.6.5 to v3.6.6, a minor backend/metadata change without affecting the study content.SummaryDifference0.0%

- Check9 days agoChange DetectedA new line appears under the study identifiers: 2014 ( U.S. NIH Grant/Contract ), indicating NIH funding attribution for the trial. The addition adds funding context but does not change the study details or participant information.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA minor site version update was applied, upgrading the revision from v3.6.4 to v3.6.5. This change does not alter the study details or user-facing content on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page revision tag was updated to Revision: v3.6.4, indicating a newer version of the page was published. This likely reflects small edits or corrections applied to the page.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page revision badge updated from v3.6.2 to v3.6.3. This indicates a minor backend/content-management update, with no change to displayed study details.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now shows a revision update from v3.6.0 to v3.6.2. This appears to be a minor maintenance/update to the site behind the page and does not alter the study details or public content.SummaryDifference0.0%

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.